MetLife Investment Management LLC lowered its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 636,193 shares of the company’s stock after selling 17,741 shares during the period. Procter & Gamble comprises 0.6% of MetLife Investment Management LLC’s holdings, making the stock its 20th largest position. MetLife Investment Management LLC’s holdings in Procter & Gamble were worth $110,189,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble during the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter worth approximately $33,000. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble in the second quarter worth $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at about $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Analysts Set New Price Targets
PG has been the topic of several recent analyst reports. Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Wells Fargo & Company lifted their price objective on Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a report on Friday, November 22nd. Morgan Stanley upped their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Finally, Piper Sandler assumed coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $180.45.
Procter & Gamble Trading Up 0.1 %
Procter & Gamble stock opened at $179.54 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm’s 50 day moving average price is $170.11 and its 200-day moving average price is $168.83. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $179.54. The stock has a market cap of $422.82 billion, a P/E ratio of 30.92, a PEG ratio of 3.82 and a beta of 0.42.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.83 earnings per share. On average, equities analysts predict that The Procter & Gamble Company will post 6.96 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.24%. Procter & Gamble’s dividend payout ratio (DPR) is currently 69.48%.
Insider Transactions at Procter & Gamble
In other news, CEO Jon R. Moeller sold 7,007 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the transaction, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. This represents a 2.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the completion of the transaction, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 35,233 shares of company stock worth $6,024,234 in the last three months. Insiders own 0.18% of the company’s stock.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Consumer Staples Stocks, Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Healthcare Dividend Stocks to Buy
- 2 Generic Drug Stocks Ready to Surge in 2025
- What is the Australian Securities Exchange (ASX)
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.